Diabetic nephropathy (DN) is currently the leading cause of end-stage renal disease
globally. Given the increasing incidence of diabetes, many experts hold the view that DN will …

Diabetic nephropathy (DN) remains the most common cause for end stage renal disease
(ESRD) as the burden of diabetes increases worldwide. Nearly one-third of patients with …

Diabetic nephropathy affects 30–40% of people with diabetes, and is the leading cause of
end‐stage kidney disease. The current treatment paradigm relies on early detection …

The burden of diabetes mellitus is relentlessly increasing. Diabetic nephropathy is the most
common cause of end-stage renal disease (ESRD) worldwide and a major cause of …

Diabetic nephropathy (DN), a persistent microvascular problem of diabetes mellitus is
described as an elevated level of albumin excretion in urine and impaired renal activity. The …

Diabetic nephropathy (DN) is a major cause of end-stage renal disease and affects a large
number of individuals with diabetes. However, the development of specific treatments for DN …

Diabetic nephropathy is the commonest cause of end-stage renal disease in most
developed economies. Current standard of care for diabetic nephropathy embraces …

Highlights•The pathogenesis of diabetic nephropathy is described.•Available anti-DN agents
with different status are summarized.•The multi-link-targeted agents are potential treatments …

Diabetic kidney disease develops in approximately 40% of patients who are diabetic and is
the leading cause of CKD worldwide. Although ESRD may be the most recognizable …

Diabetic nephropathy (DN), a leading cause of end-stage renal disease (ESRD) affecting∼
20–30% diabetics, is associated with increased cardiovascular mortality. The progression of …